Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used for the treatment of patients with locally advanced or metastatic urothelial carcinoma who: Have disease progression during or following platinum-containing chemotherapy.   Have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. For treatment of patients with metastatic […]